United States · FDA National Drug Code directory
Pramipexole dihydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-035_721c81fc-fd21-4d86-ab96-9a329b8e015b
- Product NDC
- 33342-035
- Form
- TABLET
- Composition / generic term
- Pramipexole dihydrochloride
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120921
- Source listing expiry
- 20261231
Source-listed ingredients
- PRAMIPEXOLE DIHYDROCHLORIDE — 1.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 BLISTER PACK in 1 CARTON (33342-035-06) / 1 TABLET in 1 BLISTER PACK · 33342-035-06
- 90 TABLET in 1 BOTTLE (33342-035-10) · 33342-035-10
- 100 BLISTER PACK in 1 CARTON (33342-035-12) / 1 TABLET in 1 BLISTER PACK · 33342-035-12
- 500 TABLET in 1 BOTTLE (33342-035-15) · 33342-035-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →